Kura Oncology SVP Finance Thomas Doyle Sells 4,607 Shares

What Happened
Thomas J. Doyle, Senior Vice President, Finance & Accounting at Kura Oncology (KURA), disposed of 4,607 shares on 2026-09-28 at $10.50 per share, for total proceeds of $48,361. The filing reports the sale as a sell-to-cover to satisfy tax withholding tied to the vesting of performance-based restricted stock units (PSUs).

Key Details

• Transaction date and price: 2026-09-28, 4,607 shares sold at $10.50 each (total $48,361).
• Transaction type: Sale (reported as open-market/private sale; identified in footnote as sell-to-cover for taxes).
• Shares owned after transaction: Not specified in this Form 4.
• Notable footnotes:
  • F1: Sale was a sell-to-cover for taxes on the vesting of 1/6th of the underlying PSUs granted May 31, 2023. The one-year anniversary of a specified development milestone was met on 2026-09-27, triggering that vesting tranche.
  • F2: Filing notes inclusion of 1,868 shares acquired on 2026-05-17 under the company Employee Stock Purchase Plan (ESPP).
• Filing timeliness: Reported on 2026-09-29 for the 2026-09-28 transaction (filed the next day; appears timely under Section 16 reporting rules).

Context
Sell-to-cover transactions are routine tax-withholding actions when restricted stock or PSUs vest and do not necessarily signal stock-view changes by the insider. The sale here was triggered by vesting of performance-based awards tied to development milestones, not an independent open-market trade to raise cash.